Results 91 to 100 of about 11,553 (254)

REGULATORY APPROVAL OF NEW MEDICAL DEVICES: A CROSS SECTIONAL STUDY [PDF]

, 2016
Objective To investigate the regulatory approval of new medical devices. Design Cross sectional study of new medical devices reported in the biomedical literature.
Darzi, A, Hughes-Hallett, A, Marcus, AP, Marcus, HJ, Nandi, D, Payne, CJ, Yang, GZ   +6 more
core   +2 more sources

Single access in complex angioplasty using the ventricular support system Impella CP™ [PDF]

, 2021
Marcelo Silva Ribeiro, Luís Augusto Palma Dallan, Gustavo Neves, Luciana Simoni, Carlos M. Campos, Rodrigo Vugman Wainstein   +5 more
openalex   +1 more source

Prognostic Value of Antiarrhythmic Drug Suppression of Electrical Storm Prior to Ventricular Tachycardia Ablation

Journal of Cardiovascular Electrophysiology, Volume 36, Issue 12, Page 3310-3320, December 2025.
Kaplan Meir survival curves comparing the elective and urgent groups from time of ablation. Top Left: Long‐term survival. Top Right: VT‐free survival. Bottom Left: ES‐free survival. Bottom Right: Repeat ablation‐free survival. Long term survival was significantly improved in the elective group.
Rafik Issa, Osama El‐Sayed, Mohammed Al‐Sadawi, Muazzum Shah, Kelly Arps, Amrish Deshmukh, Michael Ghannam, Rakesh Latchamsetty, Krit Jongnarangsin, Thomas Crawford, Aman Chugh, Hakan Oral, Fred Morady, Frank Bogun, Jackson J. Liang   +14 more
wiley   +1 more source

Fully percutaneous insertion and removal of the Impella CP via a subclavian approach

Advances in Interventional Cardiology, 2020
The Impella (Abiomed) is a mechanical circulatory support device which augments cardiac output, but may also unload a left ventricle during venoarterial extracorporeal membrane oxygenation (ECMO) [1].
Jerzy Sacha, Krzysztof Krawczyk, Marek Gierlotka   +2 more
doaj   +1 more source

Relationship between Pre-Implant Interleukin-6 Levels, Inflammatory Response, and Early Outcome in Patients Supported by Left Ventricular Assist Device: A Prospective Study [PDF]

, 2014
Purpose: The immune response is crucial in the development of multi-organ failure (MOF) and complications in end-stage heart failure patients supported by left ventricular assist device (LVAD).
Botta, Luca, Caruso, Raffaele, Frigerio, Maria, Martinelli, Luigi, Milazzo, Filippo, Paino, Roberto, Parodi, Oberdan, Trivella, Maria Giovanna, Vecchi, Irene, Verde, Alessandro   +9 more
core   +2 more sources

Long‐Term Outcomes of Catheter Ablation in Ventricular Tachycardia Electrical Storm: A Retrospective Cohort Study

Clinical Cardiology, Volume 48, Issue 11, November 2025.
Despite high acute success, catheter ablation for electrical storm is associated with substantial recurrence and mortality. This study emphasizes the complex substrate and high‐risk profile of this population, underscoring the need for careful long‐term management.
Cem Çöteli, Samuray Zekeriyayev, Can Sezer, Hikmet Yorgun, Kudret Aytemir   +4 more
wiley   +1 more source

Single Center Experience With Impella 5.5 for Escalation and De-Escalation of Cardiogenic Shock Patients

Journal of Interventional Cardiology
Temporary mechanical circulatory support (tMCS) devices are a critical component for treating patients with cardiogenic shock (CS). We analyzed use of Impella 5.5 device for efficacy and safety in a single-center CS population from February 2022 and ...
Ioana Dumitru, Debbie Rinde-Hoffman, Maria Sevillano, Leeandra Schnell, Elizabeth Quintilliani, Swaroop Bommareddi   +5 more
doaj   +1 more source

Lung ultrasound and mortality in a cardiogenic shock population: A prospective registry‐based analysis

European Journal of Heart Failure, Volume 27, Issue 11, Page 2594-2603, November 2025.
Lung ultrasound (LUS) and mortality in cardiogenic shock (CS) patients. Abstract Aims Lung ultrasound (LUS) is a widely used technique to assess de‐aeration in critically ill patients with respiratory failure. There is paucity of data on LUS in cardiogenic shock (CS).
Guido Tavazzi, Costanza Natalia Julia Colombo, Matteo Pagnesi, Maurizio Bertaina, Andrea Montisci, Simone Frea, Marco Marini, Martina Briani, Lisa Patrini, Francesca Rossi, Letizia Bertoldi, Giulia Maj, Giovanna Viola, Carlotta Sorini Dini, Serafina Valente, Gaetano Maria De Ferrari, Nuccia Morici, Federico Pappalardo, Alice Sacco, on behalf of the Altshock Group   +19 more
wiley   +1 more source

Surgically implanted endovascular, microaxial left ventricular assist device: A single institution studyCentral MessagePerspective

JTCVS Techniques
Objective: The Impella 5.5 (Abiomed, Inc), a surgically implanted endovascular microaxial left ventricular assist device, is increasingly used worldwide and there have been more than 10,000 implants.
Erin M. Schumer, MD, MPH, Yun Zhu Bai, MD, Kunal D. Kotkar, MD, M. Faraz Masood, MD, Akinobu Itoh, MD, PhD, Joel D. Schilling, MD, PhD, Gregory A. Ewald, MD, Marci S. Damiano, MSN, Irene Fischer, MPH, Tsuyoshi Kaneko, MD, Ralph J. Damiano, MD, Amit Pawale, MD   +11 more
doaj   +1 more source

Influence of Timing and Predicted Risk on Mortality in Impella-Treated Infarct-Related Cardiogenic Shock Patients

Frontiers in Cardiovascular Medicine, 2020
Background: In-hospital mortality in acute myocardial infarction-related cardiogenic shock (AMI-CS) remains high. The only adequately powered randomized trial showed no benefit of routine use of the intra-aortic balloon pump in AMI-CS.
Andreas Schäfer, Nikos Werner, Nikos Werner, Daniel Burkhoff, Jan-Thorben Sieweke, Andreas Zietzer, Maryna Masyuk, Nanna Louise Junker Udesen, Ralf Westenfeld, Jacob Eifer Møller   +9 more
doaj   +1 more source